Skip to main content
lab-experiment-feat

Office of Research and Technology Management’s Joseph Jankowski discusses timeline for drug developments to be seen at patient level

Media | September 09, 2019 | Story by: Editorial Staff

UA spinoff creating 3-D cell models for cancer research

Crain’s Cleveland BusinessJoseph Jankowski, chief innovation officer in the Office of Research and Technology Management, discussed how there can be a long turnaround in seeing an advance in drug development being implemented for patients.